Dalian Bio-Chem's employee stock plan unlocks for participants

Dalian Bio-Chem announced that the second lock-up period for its 2023 Employee Stock Ownership Plan, involving 5,075,932 shares, has expired. Unlocking conditions were fulfilled. Beijing Deheng Law Offices provided a legal opinion confirming the necessary approvals, authorizations, and the achievement of unlocking conditions for the plan. The plan's second lock-up period ended on October 16, 2025, meeting the 24-month interval requirement from the stock transfer completion date of October 17, 2023.

The company met the performance targets for the second unlocking period, achieving a 2024 operating income growth rate of 23.09%, exceeding the 10% target. Furthermore, 83 participants achieved an "excellent" performance rating, allowing them to unlock 100% of their shares, while one participant rated "unqualified" and two resigned. The shares held by these individuals will be recovered and reallocated by the management committee.

Following the 2024 annual equity distribution on May 23, 2025, the company's total share capital increased to 706,223,654 shares. The employee stock ownership plan's share count also adjusted from 3,625,666 shares to 5,075,932 shares due to the dividend distribution of 0.60 yuan per share and a stock dividend of 0.4 shares per share.